What TEE Reveals in Stroke Evaluation
TEE is the most sensitive and specific imaging technique for detecting left atrial (LA) and left atrial appendage (LAA) thrombus—the primary cardiac source of embolic stroke—far surpassing transthoracic echocardiography. 1
Primary Diagnostic Capabilities
Definite Embolic Sources (High-Risk Findings)
TEE identifies definite cardiac sources of embolism in approximately 21-22% of stroke patients:
- LA/LAA thrombus (most common—found in 12-14% of cases) 2
- Vegetations from infective endocarditis (sensitivity 90-100%) 3, 4
- Mobile aortic arch thrombi (3-4% of cases) 2
- Prosthetic valve dysfunction or thrombus 2, 5
- Cardiac tumors (rare, <1%) 2
- Left ventricular thrombus (2-3% of cases) 2
Potential Embolic Sources (Moderate-Risk Findings)
TEE detects potential sources in an additional 52-62% of patients without definite sources:
- Patent foramen ovale (PFO) with right-to-left shunt—found in 27-58% of cryptogenic stroke patients 2, 5
- Atrial septal aneurysm (7-13% of cases, particularly significant when combined with PFO) 2, 5
- Complex aortic arch atheroma (plaques ≥4mm thick, ulcerated, or mobile)—present in 34-54% of cases 6, 2
- LA spontaneous echo contrast (21-29% of cases, indicating blood stasis) 2, 7
- Reduced LAA flow velocity (<20 cm/sec) 8
- Atrial septal defects 2
Clinical Impact on Management
TEE findings alter stroke management in approximately 39% of cryptogenic stroke cases 5:
- Initiation of anticoagulation in 9% of patients initially in sinus rhythm 9
- Referral for cardiac surgery (endocarditis, valve dysfunction, large thrombi)
- Percutaneous PFO/ASD closure in 22% of appropriate candidates 5
- Modification of antithrombotic strategy based on identified sources
Specific Clinical Scenarios Where TEE is Essential
Mandatory Indications (Class I Recommendations)
- Before cardioversion in atrial fibrillation/flutter lasting >48 hours without adequate anticoagulation—to exclude LA/LAA thrombus 8, 1
- Cryptogenic stroke in patients <65 years with negative TTE and carotid studies 5
- Suspected endocarditis when TTE is nondiagnostic or complications are suspected 3, 4
- High-risk patients requiring detailed assessment of cardiac anatomy and aortic arch 10, 11
TEE vs TTE: Critical Distinctions
TTE limitations that necessitate TEE:
- Sensitivity for LA/LAA thrombus: only 36-69% 3
- Cannot adequately visualize aortic arch atheroma 6
- Misses 75% of sinus venosus ASDs 12
- Poor visualization in mechanically ventilated or obese patients 11
TEE advantages:
- 90-100% sensitivity for vegetations and thrombi 3, 4
- Superior visualization of posterior cardiac structures
- Definitive assessment of PFO with bubble study
- Detailed evaluation of aortic arch pathology 6
Important Caveats
Limitations to Recognize
- Absence of thrombus does not eliminate stroke risk—anticoagulation may still be needed based on clinical factors 8, 1
- Cannot differentiate active from healed vegetations 3
- Small portion of ascending aorta masked by tracheal air column (2% of plaques missed) 6
- Incidental findings are common—must distinguish clinically significant from incidental abnormalities 13
When TEE May Not Change Management
- Established atrial fibrillation already requiring anticoagulation
- Large territorial infarcts with clear large-vessel atherosclerotic etiology
- Patients >65 years with multiple vascular risk factors and negative TTE (lower yield for actionable findings)
Practical Implementation
Timing: Perform TEE as soon as possible (within 12 hours) when indicated, particularly before cardioversion or when urgent management decisions depend on findings 4
Repeat TEE: Consider 7-10 days after initial negative study if clinical suspicion persists or new complications develop during treatment 4
Risk-benefit: TEE requires conscious sedation and has inherent procedural risks (aspiration, esophageal injury), but these are minimal compared to the diagnostic yield in appropriate patients 10, 11